Making sense of agility, scaling, OKRs, product operating models, and leadership — written from 15+ years in the field.
Molecule-to-Medicine Bio needed diverse R&D teams and portfolio companies to collaborate better under scientific uncertainty. Yuval introduced pragmatic Scrum and Kanban patterns, shared visibility, and iterative learning loops that improved traction, risk management, and cross-company alignment.
Read more →
SAFe splits product ownership between Product Manager and Product Owner. This guide explores the tradeoffs, common failure modes, and practical ways to make it work.
Read more →
A conversation with SAFe Fellow Adam Mattis on the value of flow: Flow metrics, Value Streams, and using flow as a lens for driving change management in SAFe organizations.
Read more →
Business scaling constraints live above the team and program level. Elevating agility to the company development level — where strategy, culture, and structure interact.
Read more →
Layoffs of Scrum Masters and Agile Coaches don't signal agile nirvana — they signal a reckoning. What the reduction in agile roles actually means, why it's happening, and what you should do about it.
Read more →
The connection between business agility, OKRs, and private equity returns — a podcast interview on how PE portfolio companies can use OKRs to create real strategic traction.
Read more →